An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension

BACKGROUND: Hereditary angioedema (HAE) is characterized by recurrent attacks of subcutaneous or submucosal edema. Attacks are unpredictable, debilitating, and have a significant impact on quality of life. Patients may be prescribed prophylactic therapy to prevent angioedema attacks. Current prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedl, Marc A., Bernstein, Jonathan A., Craig, Timothy, Banerji, Aleena, Magerl, Markus, Cicardi, Marco, Longhurst, Hilary J., Shennak, Mustafa M., Yang, William H., Schranz, Jennifer, Baptista, Jovanna, Busse, Paula J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629784/
https://www.ncbi.nlm.nih.gov/pubmed/29043014
http://dx.doi.org/10.1186/s13601-017-0172-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629784/
https://www.ncbi.nlm.nih.gov/pubmed/29043014
http://dx.doi.org/10.1186/s13601-017-0172-9

Ejemplares similares